Table 2 Associations between exposure to Mwanamphepo during pregnancy and adverse pregnancy outcomes (Mixed-effects model, adjusted for clustering)
Outcome measures | Total n (%) | Non-exposed n (%) | Exposed n (%) | COR (95% CI) p-value | aAOR (95% CI) p-value |
|---|---|---|---|---|---|
Maternal morbidity | |||||
 No (Rc) | 6100 (74.2%) | 4665 (76.4%) | 1435 (67.9%) |  |  |
 Yes | 2119 (25.8%) | 1441 (23.6%) | 678 (32.1%) | 1.21 (1.05–1.38) 0.006 | 1.28 (1.09–1.50) 0.002 |
Neonatal death or morbidity | |||||
 No (Rc) | 3538 (43.1%) | 2795 (45.8%) | 744 (35.2%) |  |  |
 Yes | 4680 (56.9%) | 3311 (54.2%) | 1369 (64.8%) | 1.30 (1.16–1.46) < 0.001 | 1.22 (1.06–1.40) 0.006 |